The Trimeric Artesunate Analog TF27, a Broadly Acting Anti-Infective Model Drug, Exerts Pronounced Anti-SARS-CoV-2 Activity Spanning Variants and Host Cell Types

Starting in 2019, the spread of respiratory syndrome coronavirus 2 (SARS-CoV-2) and the associated pandemic of the corona virus disease (COVID-19) has led to enormous efforts in the development of medical countermeasures. Although innovative vaccines have scaled back the number of severe COVID cases...

Descripción completa

Detalles Bibliográficos
Autores principales: Hahn, Friedrich, Wangen, Christina, Häge, Sigrun, Herrmann, Lars, Herrmann, Alexandra, Tsogoeva, Svetlana B., Marschall, Manfred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866877/
https://www.ncbi.nlm.nih.gov/pubmed/36678744
http://dx.doi.org/10.3390/pharmaceutics15010115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866877/
https://www.ncbi.nlm.nih.gov/pubmed/36678744
http://dx.doi.org/10.3390/pharmaceutics15010115

Ejemplares similares